| Target Price | $895.05 |
| Price | $569.51 |
| Potential | 57.16% |
| Number of Estimates | 20 |
| 20 Analysts have issued a price target Axon Enterprise Inc 2026 . The average Axon Enterprise Inc target price is $895.05. This is 57.16% higher than the current stock price. The highest price target is $1,050.00 84.37% , the lowest is $670.74 17.78% . | |
| A rating was issued by 27 analysts: 24 Analysts recommend Axon Enterprise Inc to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Axon Enterprise Inc stock has an average upside potential 2026 of 57.16% . Most analysts recommend the Axon Enterprise Inc stock at Purchase. |
23 Analysts have issued a sales forecast Axon Enterprise Inc 2025 . The average Axon Enterprise Inc sales estimate is $2.8b . This is 8.29% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $2.9b 14.54% , the lowest is $2.6b 1.53% .
This results in the following potential growth metrics:
| 2024 | $2.1b | 33.44% |
|---|---|---|
| 2025 | $2.8b | 33.01% |
| 2026 | $3.4b | 24.44% |
| 2027 | $4.2b | 21.99% |
20 Analysts have issued an Axon Enterprise Inc EBITDA forecast 2025. The average Axon Enterprise Inc EBITDA estimate is $700m . This is 3,892.75% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $752m 4,190.18% , the lowest is $658m 3,653.88% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $112m | 41.87% |
|---|---|---|
| 2025 | $700m | 526.43% |
| 2026 | $898m | 28.39% |
| 2027 | $1.1b | 27.93% |
| 2024 | 5.36% | 56.43% |
|---|---|---|
| 2025 | 25.25% | 370.89% |
| 2026 | 26.06% | 3.21% |
| 2027 | 27.32% | 4.83% |
22 Axon Enterprise Inc Analysts have issued a net profit forecast 2025. The average Axon Enterprise Inc net profit estimate is $537m . This is 108.92% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $647m 151.67% , the lowest is $453m 76.24% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $377m | 114.49% |
|---|---|---|
| 2025 | $537m | 42.47% |
| 2026 | $629m | 17.08% |
| 2027 | $779m | 23.94% |
| 2024 | 18.10% | 60.74% |
|---|---|---|
| 2025 | 19.39% | 7.10% |
| 2026 | 18.24% | 5.93% |
| 2027 | 18.54% | 1.64% |
22 Analysts have issued a Axon Enterprise Inc forecast for earnings per share. The average Axon Enterprise Inc EPS is $6.84 . This is 109.17% higher than earnings per share in the financial year 2024. The highest EPS forecast is $8.24 151.99% , the lowest is $5.77 76.45% .
This results in the following potential growth metrics and future valuations:
| 2024 | $4.80 | 106.01% |
|---|---|---|
| 2025 | $6.84 | 42.50% |
| 2026 | $8.01 | 17.11% |
| 2027 | $9.93 | 23.97% |
| Current | 174.98 | 60.42% |
|---|---|---|
| 2025 | 83.62 | 52.21% |
| 2026 | 71.42 | 14.59% |
| 2027 | 57.63 | 19.31% |
Based on analysts' sales estimates for 2025, the Axon Enterprise Inc stock is valued at an EV/Sales of 16.14 and an P/S ratio of 16.30 .
This results in the following potential growth metrics and future valuations:
| Current | 17.48 | 7.81% |
|---|---|---|
| 2025 | 16.14 | 7.65% |
| 2026 | 12.97 | 19.64% |
| 2027 | 10.63 | 18.03% |
| Current | 17.65 | 7.89% |
|---|---|---|
| 2025 | 16.30 | 7.66% |
| 2026 | 13.10 | 19.64% |
| 2027 | 10.74 | 18.03% |
Axon Enterprise Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Nov 06 2025 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Nov 05 2025 |
| Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Nov 05 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Nov 05 2025 |
| JMP Securities |
Market Outperform
➜
Market Outperform
|
Unchanged | Sep 29 2025 |
| Needham |
Buy
➜
Buy
|
Unchanged | Sep 24 2025 |
| Piper Sandler |
➜
Overweight
|
Initiated | Sep 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Nov 06 2025 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Nov 05 2025 |
|
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Nov 05 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Nov 05 2025 |
|
Unchanged
JMP Securities:
Market Outperform
➜
Market Outperform
|
Sep 29 2025 |
|
Unchanged
Needham:
Buy
➜
Buy
|
Sep 24 2025 |
|
Initiated
Piper Sandler:
➜
Overweight
|
Sep 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


